<?xml version='1.0' encoding='utf-8'?>
<document id="21441623"><sentence text="Induction of P450 3A1/2 and 2C6 by gemfibrozil in Sprague-Dawley rats."><entity charOffset="35-46" id="DDI-PubMed.21441623.s1.e0" text="gemfibrozil" /></sentence><sentence text="Fibrates are a group of peroxisome proliferator-activated receptor Î± agonists used in the treatment of dyslipidemia; however, they have been reported to cause species-related hepatocarcinogenesis and clinical myotoxicity" /><sentence text=" Gemfibrozil is one of the most commonly used fibrates, and it shows the highest risk for myotoxicity among the fibrates"><entity charOffset="1-12" id="DDI-PubMed.21441623.s3.e0" text="Gemfibrozil" /></sentence><sentence text=" The inhibitory drug-drug interaction mechanism associated with gemfibrozil has been explored recently, and the induction of human P450 3A4 and 2C8 has been reported"><entity charOffset="64-75" id="DDI-PubMed.21441623.s4.e0" text="gemfibrozil" /></sentence><sentence text=" In this study, in vivo induction of rat P450 by gemfibrozil was studied in Sprague-Dawley rats"><entity charOffset="49-60" id="DDI-PubMed.21441623.s5.e0" text="gemfibrozil" /></sentence><sentence text=" After the rats were dosed with gemfibrozil by oral gavage, microsomes were prepared"><entity charOffset="32-43" id="DDI-PubMed.21441623.s6.e0" text="gemfibrozil" /></sentence><sentence text=" The metabolic activities of P450 3A1/2, 2C6, and 2D2 were assayed using probe substrates, and the systemic concentration of gemfibrozil during its administration was determined"><entity charOffset="125-136" id="DDI-PubMed.21441623.s7.e0" text="gemfibrozil" /></sentence><sentence text=" P450 3A1/2 and 2C6 activities were induced 32-77% in the rats by gemfibrozil when the exposure concentration was in the clinical range"><entity charOffset="66-77" id="DDI-PubMed.21441623.s8.e0" text="gemfibrozil" /></sentence><sentence text=" These data indicate that the inducibility of homologous P450 isoforms by gemfibrozil is similar in Sprague-Dawley rats and in humans"><entity charOffset="74-85" id="DDI-PubMed.21441623.s9.e0" text="gemfibrozil" /></sentence><sentence text=" Inductive drug-drug interactions and inhibitory actions are involved in the co-administration of gemfibrozil with other drugs, which suggests the relevance for a fibrate-toxicology investigation"><entity charOffset="98-109" id="DDI-PubMed.21441623.s10.e0" text="gemfibrozil" /><entity charOffset="163-170" id="DDI-PubMed.21441623.s10.e1" text="fibrate" /><pair ddi="false" e1="DDI-PubMed.21441623.s10.e0" e2="DDI-PubMed.21441623.s10.e0" /><pair ddi="false" e1="DDI-PubMed.21441623.s10.e0" e2="DDI-PubMed.21441623.s10.e1" /></sentence><sentence text="" /></document>